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Abstract. 
 
Myosin II thick ﬁlament assembly in 
 
Dictyo-
stelium
 
 is regulated by phosphorylation at three thre-
onines in the tail region of the molecule. Converting 
these three threonines to aspartates (3
 
3
 
Asp myosin 
II), which mimics the phosphorylated state, inhibits ﬁla-
ment assembly in vitro, and 3
 
3
 
Asp myosin II fails to 
rescue myosin II–null phenotypes. Here we report a 
suppressor screen of 
 
Dictyostelium
 
 myosin II–null cells 
containing 3
 
3
 
Asp myosin II, which reveals a 21-kD re-
gion in the tail that is critical for the phosphorylation 
control. These data, combined with new structural evi-
dence from electron microscopy and sequence analyses, 
provide evidence that thick ﬁlament assembly control 
involves the folding of myosin II into a bent monomer, 
which is unable to incorporate into thick ﬁlaments. The 
data are consistent with a structural model for the bent 
monomer in which two speciﬁc regions of the tail inter-
act to form an antiparallel tetrameric coiled–coil struc-
ture.
Key words: myosin II • thick ﬁlament assembly • 
 
Dic-
tyostelium
 
 • phosphorylation • suppressor screen
 
T
 
HE
 
 spatial and temporal control of the assembly and
disassembly of organelles is fundamental to cell and
developmental biology. The cytoskeleton is particu-
larly dynamic in vivo, responding to both internal and ex-
ternal signals that induce rapid changes in assembly state.
A key component of the actin-based cytoskeleton is myo-
sin II, which has been shown to be essential for cytokinesis
of 
 
Dictyostelium
 
 cells in suspension as well as for efficient
chemotaxis and morphogenetic changes in shape during
development (De Lozanne and Spudich, 1987; Knecht and
Loomis, 1987; Zang and Spudich, 1998). All of these roles
require myosin II to be in the form of thick filaments.
A myosin II molecule consists of a pair of heavy chains
and two pairs of light chains. Each heavy chain starts with
an NH
 
2
 
-terminal globular head, which has ATPase and
motor activity, followed by a long 
 
a
 
-helical tail. Analysis
of the tail sequences of muscle and nonmuscle myosin IIs
reveals multiple repeating patterns throughout the entire
domain that enable the two tails to form an 
 
a
 
-helical
coiled–coil rod. The smallest repeat motif consists of seven
amino acids occupied at position a–g in the helical turn.
Generally, small and hydrophobic residues are found in
positions a and d, which form the core and are essential to
the formation of the coiled–coil structure (Parry, 1981). In
all myosin IIs examined, the region of the coiled–coil tail
that is required for assembly into thick filaments is in the
COOH-terminal half of the tail.
In 
 
Dictyostelium
 
, myosin II molecules constantly relo-
cate to multiple locations for participating in various pro-
cesses. When a cell migrates, myosin II accumulates in the
posterior of the cell. During cell division, myosin II accu-
mulates in the cleavage furrow. To accomplish its cellular
tasks, myosin II is thought to assemble into bipolar thick
filaments and pull together oppositely oriented actin fila-
ments to produce contractile forces. Mutant forms of myo-
sin II that do not assemble into bipolar thick filaments in
vitro fail to rescue myosin-null phenotypes, and they do
not localize to the furrow during cytokinesis (Fukui et al.,
1990; Sabry et al., 1997). Interestingly, neither motor activ-
ity nor the existence of the myosin catalytic domain is nec-
essary for myosin II transportation in cells (Yumura and
Uyeda, 1997; Zang and Spudich, 1998).
The mechanism for 
 
Dictyostelium
 
 myosin filament as-
sembly is thought to proceed in two distinctive stages. The
initial slower step occurs by sequential association of myo-
sin II monomers into parallel dimers and antiparallel tet-
ramers. The next step is rapid lateral addition of myosin
dimers to bipolar nuclei to form thick filaments (Mahajan
and Pardee, 1996). A single point mutation in the tail do-
main has been shown to be sufficient to inhibit 
 
Dictyostel-
ium
 
 myosin II filament assembly in vitro, apparently by
preventing the formation of dimers and antiparallel tet-
ramers (Moores and Spudich, 1998).
The initial step of filament assembly for 
 
Dictyostelium
 
myosin II is thought to be induced by dephosphorylation
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of phosphorylated sites in the tail. Target sites for this
phosphorylation control have been mapped to three thre-
onines at positions 1823, 1833, and 2029 (denoted TTT)
(Vaillancourt et al., 1988; Luck-Vielmetter et al., 1990).
These three threonines are located in a regulatory domain
that is 
 
z
 
23% (34 kD) of the length of the tail, starting
from the COOH terminus. A short designation for myo-
sins with different amino acids at positions 1823, 1833, and
2029 takes the form of XXX, where X uses the single
amino acid code at each of the three positions. NH
 
2
 
-termi-
nal to the regulatory domain, another 34-kD region has
been shown to be the smallest fragment of 
 
Dictyostelium
 
myosin II that is necessary and sufficient for self-assembly
(O’Halloran et al., 1990; Shoffner and De Lozanne, 1996).
This region is denoted as the assembly domain.
Pasternak et al. (1989) reported evidence from electron
microscopy that phosphorylation of the heavy chain pro-
moted a bent conformation of myosin II at approximately
two-thirds the length of the tail from the head-neck junc-
tion, and these bent myosin II molecules appeared to be
excluded from the myosin filament. Further information
was obtained from mutant myosin IIs, with the phosphory-
latable threonines replaced by either three aspartates or
three alanines, expressed in myosin II–null cells (denoted
3
 
3
 
Asp and 3
 
3
 
Ala cells, respectively) (Luck-Vielmetter
et al., 1990; Egelhoff et al., 1993). 3
 
3
 
Asp myosin II mim-
icked the phosphorylated state, did not assemble into thick
filaments in vitro, and failed to rescue myosin II–null phe-
notypes. Opposite to the 3
 
3
 
Asp mutant, 3
 
3
 
Ala myosin II
assembled similar to wild-type myosin II in vitro. These
data led to the hypothesis that after being phosphorylated,
myosin II monomers prefer a bent conformation that is
not able to assemble into parallel dimers, the initial unit
for filament assembly (Pasternak et al., 1989). In this re-
port we present a structural model for the myosin II bent
monomer and provide evidence that two specific alanine-
rich regions of the tail interact to form an antiparallel tet-
rameric coiled–coil structure.
 
Materials and Methods
 
Cell Culture
 
Dictyostelium
 
 myosin II–null cells (HS1), transformed with pBigMyD to
create wild-type myosin II cells (Ruppel et al., 1994) and with pBIG-ASP
to create 3
 
3
 
Asp myosin II cells, were grown as described (Egelhoff et al.,
1993). The HL-5 growth medium was supplemented with 60 
 
m
 
g/ml strep-
tomycin, 60 U/ml penicillin, and 5 
 
m
 
g/ml G418 (Geneticin; Life Technolo-
gies, Inc.). Bacterial lawns were prepared by spreading 2 ml of an over-
night 
 
Klebsiella aerogenes
 
 culture on SM/5 plates (Sussman, 1987).
Transformations were performed by electroporation (Egelhoff et al.,
1991a) and transformed cells were selected by 5 
 
m
 
g/ml G418.
 
Mutagenesis and Clonal Isolation of Suppressors for 
3
 
3
 
Asp Myosin II Cells
 
Suppressors of 3
 
3
 
Asp myosin II cells were generated by treatment with
4-nitroquinoline-
 
N
 
-oxide (NQNO)
 
1
 
 or UV irradiation. Conditions for
treatment of 3
 
3
 
Asp myosin II cells using chemical mutagen NQNO were
as described by Patterson and Spudich (1995). After treatment with
NQNO, cells were shaken in suspension for 30 min, washed twice with
HL-5, and 1.2 
 
3
 
 10
 
6
 
 cells were plated onto bacterial lawns. For suppres-
sors generated by UV irradiation, 1.2 
 
3
 
 10
 
6
 
 3
 
3
 
Asp myosin II cells were
 
spotted onto plates containing bacterial lawn and irradiated with UV
(0.8–6.4 mJ/cm
 
2
 
).
Plates from either treatment were placed at 22
 
8
 
C and the developmen-
tal phenotype was observed 5 d later to screen for suppressors, which re-
covered the ability to sporulate. Clonal isolation of suppressors was per-
formed as follows: a single sorus from each plaque was picked by a sterile
pipet tip, resuspended in 5 ml HL-5, and spread on a new bacterial lawn to
obtain single plaques.
 
Mutation Mapping and Reconstruction
 
The tail region of each suppressor was sequenced using standard methods
to locate each mutation. The mutations were then introduced into the
3
 
3
 
Asp myosin II sequence by PCR overlap extension mutagenesis (Ho
et al., 1989), and then subcloned into pLittleMyo (Moores and Spudich,
1998). These constructs were subsequently transformed into myosin II–
null cells, and the developmental phenotypes were examined.
 
Electrophoresis and Immunoblotting
 
Whole-cell lysates were electrophoresed on SDS/7.5% polyacrylamide
gels and transferred to nitrocellulose paper. The paper was probed with
anti-
 
Dictyostelium 
 
myosin II mAbs, My6 (Peltz et al., 1985) or mAb 55
(kindly provided by Dr. Guenther Gerisch, Max Planck Institut für Bio-
chemie, Martinsried, Germany) (Pagh and Gerisch, 1986), and then incu-
bated with a HRP-coupled secondary antibody (Bio-Rad). Signals were
visualized with an enhanced chemiluminescence system (DuPont).
 
Protein Purification
 
Wild-type and 3
 
3
 
Asp myosin IIs were purified from cells grown and har-
vested as described (Egelhoff et al., 1993), after a modified purification
protocol that does not require filament assembly (Moores and Spudich,
1998). After being washed with 10 mM Tris-HCl, 1 mM EDTA, pH 7.5,
the cell pellets were resuspended in 2 vol/g cells 25 mM Hepes, 50 mM
NaCl, 2 mM EDTA, 1 mM DTT, pH 7.4, containing a mixture of protease
inhibitors (buffer A) (Moores and Spudich, 1998). The cell suspension was
frozen by dripping into liquid nitrogen and stored at 
 
2
 
80
 
8
 
C. Immediately
before preparation, frozen pellets were thawed and lysed in 7 vol/g cells
buffer A at 0
 
8
 
C. After sedimentation at 36,000 
 
g
 
 for 30 min, the pellets
were suspended in 4 vol/g cells 10 mM Hepes, 130 mM NaCl, 1 mM
EDTA, 1 mM DTT, pH 7.4. The cell suspension was centrifuged at 36,000 
 
g
 
for 15 min. Extraction of myosin II was achieved by resuspending the pel-
lets in 1.5 vol/g cells 10 mM Hepes, 150 mM NaCl, 5 mM MgCl
 
2
 
, 4 mM
ATP, and 1 mM DTT, pH 7.4. After centrifugation at 200,000 
 
g
 
 for 30 min,
RNase A (5 
 
m
 
g/ml) and PMSF (0.1 mM) were added to the supernatant.
The solution was dialyzed against a 12% Aquacide III (Calbiochem) solu-
tion in 10 mM Hepes, 200 mM NaCl, 1 mM DTT, pH 7.4, to concentrate
the volume 
 
z
 
20-fold, and further dialyzed in 10 mM Hepes, 200 mM
NaCl, 1 mM DTT, pH 7.4 (column buffer). After adding 0.6 M potassium
iodide, 20 mM sodium pyrophosphate, and 2 mM ATP, the concentrated
dialysate was loaded onto a Biogel A15 gel (Bio-Rad) filtration column
(80 ml total volume), which had been equilibrated previously with column
buffer and preloaded with 10 ml 0.6 M KI, 20 mM NaPPi. Fractions con-
taining myosin II were pooled and concentrated as mentioned before.
Typical final concentrations for myosin IIs were 1–3 mg/ml, as determined
by the Bradford method (Bradford, 1976), using rabbit skeletal muscle
myosin II as the standard.
 
Rotary Shadowing EM and Analysis
 
Samples were diluted to 30–50 
 
m
 
g/ml myosin II in 50–70% glycerol, 10 mM
Hepes, 200 mM KCl, 1 mM DTT, pH 7.4, and sprayed immediately onto
freshly cleaved mica and viewed as described (Flicker et al., 1985). The lo-
cations of bends along the tail of myosin II monomers were measured on
prints.
 
Results
 
Suppressors for 3
 
3
 
Asp Myosin II Cells Were
All Intragenic
 
We used a random mutagenesis approach to identify sup-
pressors responsible for recovery of myosin II function for
 
1. 
 
Abbreviation used in this paper:
 
 NQNO, 4-nitroquinoline-
 
N
 
-oxide. 
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3
 
3
 
Asp myosin II cells. 3
 
3
 
Asp myosin II cells are pheno-
typically identical to myosin II–null cells (Egelhoff et al.,
1993). Both fail to complete the 
 
Dictyostelium
 
 devel-
opmental cycle. They arrest at the mound stage (Fig. 1
B). After treatment of cells with the chemical mutagen
NQNO or UV irradiation, 3
 
3
 
Asp myosin II cells were
spread on bacterial lawns. Any colony that developed past
the mound stage was scored as a suppressor. Depending
on the extent of suppression, the suppressors were sorted
into three groups: limited, medium, and full (Fig. 1, C–E).
Mutagenesis was performed on a strain of 
 
Dictyostelium
 
that had its endogenous 
 
mhcA
 
 gene deleted (HS1) and
contains an extrachromosomal plasmid expressing 
 
mhcA
 
–
3
 
3
 
Asp myosin II (pBIG-ASP). To check whether the sup-
pressor mutations were intragenic or extragenic, the plas-
mid from each suppressor was rescued and retransformed
into unmutagenized myosin II–null cells, and the trans-
formed cells were spread on bacterial lawns. The pheno-
types of all the suppressors were reproduced, verifying
that all 28 suppressor mutations were intragenic. The char-
acteristics of the suppressors are shown in Table I. Typi-
cally the expression level of myosins from the suppressors
was similar to that from the wild-type and 3
 
3
 
Asp myosin
II cells, but the size of the myosins varied (Fig. 2). 7 of 28
of the suppressors were full-length myosin II, 9 were small
internal deletions of 1–7 residues, and 12 were truncations
from the COOH terminus. There was no correlation be-
tween the means of mutagenesis (NQNO or UV) and the
sizes of myosin IIs expressed from the suppressors. The
sizes of the 12 
 
D
 
COOH terminus suppressor myosin IIs
were the same or larger than a previously studied mutant
myosin II called 
 
D
 
C34. 
 
D
 
C34–myosin II, a truncated 
 
Dic-
tyostelium
 
 myosin II lacking the 34-kD COOH terminus of
the tail (the regulatory domain, residues 1819–2116; see
Fig. 3), constitutively assembles into thick filaments, and
 
D
 
C34–myosin cells are able to complete the
 
 Dictyostelium
 
developmental cycle and form fruiting bodies (O’Halloran
and Spudich, 1990). Our 
 
D
 
COOH terminus myosin II sup-
pressors are likely to be longer variants of the 
 
D
 
C34–myo-
sin II constitutive assembly phenotype, and we therefore
focused on the remaining 16 suppressors.
 
The Myosin II Suppressor Mutations All Mapped to a 
Specific Region of the Tail
 
Sequencing results for all of the 16 full-length or near full-
length suppressors revealed mutations that strikingly all
lie in a 21-kD region (
 
z
 
182 amino acids) towards the
COOH terminus of the tail (Fig. 3). All of the seven
suppressors with single residue mutations resulted from
changes of a single nucleotide base pair. The strongest
suppressor was strain D1823Y, which had an aspartate to
tyrosine mutation at position 1823 (denoted YDD). This
position is one of the three targets for myosin II heavy
chain kinase (Egelhoff et al., 1993). This residue corre-
sponds to position d in the heptad repeat of the myosin
II tail. The rest of the suppressors with single residue
changes resulted in the introduction of a proline, which
does not exist in the tail of wild-type 
 
Dictyostelium
 
 myosin
II. Interestingly, three independent suppressors recovered
from our screen affected Arg 1880, and two affected Arg
Figure 1. Developmental phenotypes of Dictyostelium cells ex-
pressing various forms of myosin II in the myosin II–null cells.
(A) Wild-type myosin II. (B) 33Asp myosin II. The develop-
mental phenotype of 33Asp myosin II cells is identical to that of
the myosin II–null cells. (C) Myosin II from a limited suppressor.
(D) Myosin II from a medium suppressor. (E) Myosin II from
a full suppressor. (F) Recreated full suppressor mutant 33
Asp-D1823Y. (G) Recreated limited suppressor mutant 33Asp-
R1880P. (H) Recreated medium suppressor mutant 33Asp-
D1968.
 
Table I. Characteristics of Suppressors
 
Suppressor name Method created
Extent of
suppression*
No. of
occurrences
 
Full-length myosin
 
mhcA
 
 D1823Y NQNO Full 1
 
mhcA
 
 R1880P NQNO Limited 3
 
mhcA
 
 A1914P NQNO Limited 1
 
mhcA
 
 R1926P NQNO Limited 2
Truncated myosin
 
mhcA
 
 
 
D
 
1968 UV Medium 2
 
mhcA
 
 
 
D
 
1929–1930 NQNO Medium 1
 
mhcA
 
 
 
D
 
1941–1945 UV Limited 2
 
mhcA
 
 
 
D
 
1962–1967 UV Limited 1
 
mhcA
 
 
 
D
 
1989–1995 NQNO, UV Limited 2
 
mhcA
 
 
 
D
 
1999–2004 UV Limited 1
 
mhcA
 
 
 
D
 
1987–2116 UV Limited 1
 
mhcA
 
 
 
D 
 
COOH 
terminus
NQNO, UV Full, medium,
limited
11
 
*Suppressors with full suppression have the phenotype identical to the wild-type.
With limited suppression, suppressors display short stalks with no or opaque heads.
Medium is between the full and limited suppression. See Fig. 1. Truncated myosin
suppressors lacked the COOH terminus, but their sizes were the same or larger than
 
D
 
C34–myosin. See text. 
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1926. Such multiple hits imply that these positions may
play critical roles in regulating filament assembly. The
nine small internal deletion group of suppressors had dele-
tions of one to seven amino acids in this region. As shown
in Fig. 3 B, the locations of the deletion and the single-res-
idue mutation groups did not mix. The deletions all
mapped beyond position 1926.
To be certain that the mapped mutations were responsi-
ble for the suppression phenotype and not mutations else-
where in the myosin II that we may have missed, these
mutations were recreated using PCR overlap extension
mutagenesis of a 3
 
3
 
Asp myosin II gene contained within
an extrachromosomal 
 
Dictyostelium
 
 expression vector.
The plasmids were transformed into myosin II–null cells
and the development ability on bacterial lawns was tested.
 
The sporulation phenotypes were identical to the original
suppressor strains (e.g., see Fig. 1, F–H).
 
Electron Microscopy Reveals that 3
 
3
 
Asp Myosin II Is 
Mainly in a Bent Monomer Conformation
 
Dictyostelium
 
 3
 
3
 
Asp myosin II molecules were mono-
meric at high ionic strength. Rotary shadowed 3
 
3
 
Asp my-
osin II exhibited primarily two conformations under this
condition: straight and bent monomers (Fig. 4 A). Various
forms of the bent monomers were observed. In 20% of the
bent monomer images, the COOH terminus of the tail
folded back tightly and resulted in an apparently shorter
tail (Fig. 4 A, lower panel). 77% of the 3
 
3Asp myosin II
molecules were found to be in the bent conformation (n 5
400). On the other hand, only 23% of the wild-type myosin
II molecules were found to be bent (n 5 280). The per-
centage of the bent wild-type molecules is consistent with
the previous finding that freshly purified wild-type myosin
IIs are 20–30% phosphorylated in the heavy chain (Kucz-
marski and Spudich, 1980).
The majority of the 33Asp myosin II molecules bend at
z1,200 Å, located at approximately two-thirds the length
of the tail from the head–neck junction (Fig. 4 B). This
bent position is similar to that measured for wild-type my-
osin II monomers (Pasternak et al., 1989). However, we
also observed a previously unfound, minor population of
bends at z1,000 Å (Fig. 4 B). These values are interesting,
in that they fit well with the structural motifs described be-
low for the myosin II tail. The relative proportion of bends
at 1,000 and 1,200 Å appeared to be the same in 33Asp
and wild-type myosins (z35%).
Figure 2. Examples of expression of myosin II from suppressors.
Expression of mutant myosin IIs in the myosin II–null cell line
HS1 transformed with the following suppressor mutants of
33Asp myosin II: lane 1, 33Asp myosin II control; lane 2,
D1823Y; lane 3, DCOOH terminus1; lane 4, R1880P; lane 5,
D1999–2004; lane 6, DCOOH terminus2; lane 7, R1880P; lane
8,  DCOOH terminus3; lane 9, DCOOH terminus4; lane 10,
DCOOH terminus5; and lane 11, wild-type myosin II control.
The DCOOH terminus suppressors were revealed by immuno-
blotting experiments using the mAb 55, which binds an epitope at
the COOH terminus of the tail (Pagh and Gerisch, 1986). They
failed to bind mAb 55.
Figure 3. Mapping of myosin II mutations from suppressors. Diagrammatic representation of the mutations in the Dictyostelium myo-
sin II molecule. All of the mutations were packed into a window of 182 amino acids shown in the box. Suppressors with single residue
were displayed by orange dots. Suppressors with deletion mutations were displayed by green bar(s). One vertical bar represents dele-
tion of one amino acid. The orange line denotes a region containing only point mutations and the green line indicates a region contain-
ing only deletion mutations.Liang et al. Myosin Filament Assembly Regulation 1043
The tail domain of Dictyostelium myosin II consists of
1,298 residues, and has no proline interruptions. The
coiled–coil prediction algorithm Coils (Lupas et al., 1991)
predicts small, distinct regions in the Dictyostelium myosin
II tail that have low probabilities to form a coiled–coil
structure (Fig. 5). The two most unfavorable regions for
coiled–coil structure locate at z1,000 and 1,200 Å from
the head–neck junction. Consistent with this prediction, to
optimize the pattern of charged and uncharged residues
for the periodicity of stable coiled–coil structure in the tail,
two skips of two amino acids each were necessary to be in-
serted into the tail sequence lineup at these two regions
(Warrick et al., 1986). Similar correlation between the
bends observed from EM versus skips in the tail has been
shown in smooth and skeletal muscle myosins (Offer,
1990), and in Acanthamoeba myosin (Hammer et al.,
1987). These results indicate that these two positions at
z1,000 and 1,200 Å from the head–neck junction are hinge
regions in the Dictyostelium tail domain, as seen in other
myosin IIs (Tan et al., 1992).
In another region of the tail, closer to the myosin head
(z400 Å from the head–neck junction), there is a small
area that has a somewhat lower probability to be in a
coiled–coil than the majority of the tail (Fig. 5). In C. ele-
gans, a similar domain has been described as the prehinge
(Hoppe and Waterston, 1996). A similar region (z440 Å
from the head–neck junction) predicted from muscle myo-
sin IIs has been proposed to serve as a hinge, which allows
the head domain to swing away from the thick filament,
thus allowing the myosin heads greater freedom to inter-
act with the actin filaments (Offer, 1990).
Alanine-rich Core Domains in the Tail Are Consistent 
with an Antiparallel Tetrameric Coiled–Coil Structure
An analysis of the Dictyostelium myosin II tail sequence
revealed two regions (denoted A and B) in the tail that are
unusually rich in alanine residues at the core (a or d) posi-
tions of the heptad repeats (Fig. 6). Region A spans 18
heptad repeats (between residue numbers 1383 and 1508).
Region B contains 23 heptad repeats (residue 1806–1966).
More than 75% of all of the alanines at core a and d posi-
tions along the tail are found in regions A and B, although
these regions account for only 22% of the total tail. The
300–amino acid gap between regions A and B contains the
previously identified assembly domain (O’Halloran et al.,
1990), which contains only two alanines. The midpoint of
the gap is at z1,200 Å from the head–neck junction. Core a
and d positions rich in alanine residues have been shown
to be important for the proper packing of four a-helices
into an antiparallel a-helical coiled–coil structure (Monera
Figure 4. Representative ro-
tary shadowed myosin II mol-
ecules in high ionic strength
(200 mM KCl). (A) Upper
panel: myosin II molecule in
the straight conformation.
Middle panel: myosin II mol-
ecule in a bent conformation.
Lower panel: an extreme case
of the bent conformation,
where the COOH terminus
of the tail folds back tightly
to make the molecule look
shorter. Bar, 0.1 mm. (B) Po-
sition of bend in EM images
of 33Asp myosin II mono-
mers. The majority of
33Asp myosin IIs bend at
1,200 Å, approximately two-
thirds length of the tail from
the head–neck junction. A
second region at z1000 Å
was also observed. n 5 210.
Figure 5. Coiled–coil predictions of Dictyostelium wild-type and
33Asp myosin IIs. The predictions were generated by the Coils
program (Lupas et al., 1991). x-axis, amino acid positions starting
from the head–neck junction. y-axis, probability of forming a
coiled–coil. A window of 28 amino acids was used to generate the
profiles shown.The Journal of Cell Biology, Volume 147, 1999 1044
et al., 1996). Moreover, X-ray crystal structure determina-
tion indicates that the ColE1 Rop protein forms a highly
regular four stranded a-helix bundle with alanine residues
populated in the hydrophobic core (Banner et al., 1987).
Discussion
The results presented here, together with earlier results
(Pasternak et al., 1989; Tan et al., 1992), suggest the fol-
lowing structural model of phosphorylation control of my-
osin II thick filament assembly (Fig. 7). Phosphorylation
by myosin II heavy chain kinase produces charges on the
outside of the coiled–coil tail that help stabilize the bent
form of the myosin. Bent myosin II molecules cannot asso-
ciate with other molecules to form parallel dimers, and
therefore no antiparallel tetramers appear for the next
phase of filament formation. Myosin II heavy chain phos-
phatase removes phosphates from the bent monomers,
and the molecules return to their straight conformation.
We propose that the threonine pair 1823/1833 could act as
a nucleation site, which when phosphorylated, initiates the
bent monomer conformation by orienting the two strands
of dimeric coiled–coils. Once nucleated, regions A and B
may zip up into an antiparallel four-stranded structure,
possibly similar to that observed for the ColE1 Rop pro-
tein (Banner et al., 1987). Formation of such a structure
results in a major bend at z1,200 Å from the head–neck
junction. Moreover, the previously identified assembly do-
main (Fig. 7, blue) (O’Halloran and Spudich, 1990) is se-
questered as a loop between regions A and B. This confor-
mation of the assembly domain prevents intermolecular
interactions that lead to formation of thick filaments. The
equilibrium between the bent versus straight conforma-
tions is delicately poised, and can be easily disturbed by
mutations at multiple sites in the tail (e.g., the suppressor
mutations described here; see also Moores and Spudich,
1998).
Position 1823 appears to be a particularly critical posi-
tion for switching between the bent and open conforma-
tions. YDD is the only suppressor with a full-length myo-
sin II that completely restores wild-type development.
With the aspartate to tyrosine mutation at position 1823,
YDD revives myosin II functions possibly by removing the
negatively charged aspartate at position 1823 in 33Asp
myosin II that participates in an electrostatic interaction
needed for the formation of the bent monomer. Unlike the
other two myosin heavy chain kinase sites, residue 1823
corresponds to position d of the heptad repeat of the myo-
sin tail. Position d is at the core of the coiled–coil, which
most commonly consists of hydrophobic residues. To tol-
erate a negatively charged residue at this position in the
bent conformation, it is conceivable that a positively
charged residue(s) from region A contributes in the core
of the antiparallel tetrameric coiled–coil structure. Two
possible candidates are lysine 1481 or 1526, at positions a
and d, respectively. An interruption of the heptad repeat
by polar residues has been observed in the SNARE com-
plex, which is also a highly regulated tetrameric coiled–coil
structure (Sutton et al., 1998).
The relative importance of the three threonine targets
for myosin heavy chain kinase and phosphatase have been
explored by constructing all possible combinations of thre-
onines and aspartates and examining the myosin II func-
tions (Nock, S., W. Liang, H. Warrick, and J.A. Spudich,
unpublished data). Consistent with the current report,
threonine 1823 appears to be the most critical phosphory-
lation site for myosin II functions. Simply replacing aspar-
tate at position 1823 with a threonine in 33Asp myosin II
(denoted TDD) is enough to reverse the null phenotypes
into wild-type. On the other hand, DTD partially recovers
myosin II function, which indicates that position 1833 does
play some role. Position 2029 does not appear to be re-
quired, because DDT is identical to myosin-null cells.
These arguments assume, of course, that an aspartate fully
mimics a phosphorylated threonine.
Because TDD has a wild-type phenotype, it is interest-
ing that we did not get a simple reversion from aspartate
to threonine in our suppressor screen. This could be due to
the fact that this mutation would require two nucleotide
changes, which is expected to occur in lower probability. It
has been reported that kinases that specifically phosphory-
late the three threonines also accept serines (Luck-Viel-
metter et al., 1990). The mutation from an aspartate to a
serine would also require two nucleotide changes.
The interaction within the alanine-rich core regions A
and B appears to be highly sensitive to even single amino
acid changes in the tail. All of the suppressors with single
point mutations other than YDD, are located in region B,
and except for YDD, they all involve the replacement of
an amino acid residue with proline. That a single proline at
any of three positions appears to be sufficient to destabi-
lize the antiparallel tetrameric coiled–coil domain is possi-
bly explained by its well-known disruptive effect on a-heli-
cal structure. The locations of suppressors with proline
substitutions (Fig. 7, orange) and deletion mutations (Fig.
Figure 6. Alanine-rich do-
mains in the tail of Dictyostel-
ium  myosin II. The core a
and d positions are shown for
the entire myosin II tail. Re-
gions A and B are unusually
rich in alanine residues
(shown in bold) at the core
positions of the coiled–coil
structure. The number of the
first residue in each row in
these two regions is shown.Liang et al. Myosin Filament Assembly Regulation 1045
7, green) are distinctly clustered. This suggests that the in-
teractions that lead to suppression are different in the
two sections of domain B. In one section, prolines may de-
stabilize the bent monomer by disrupting the tetrameric
coiled–coil structure. In the other section, deletions may
shift the alignment of the coiled–coil regions in the bent
monomer, resulting in disruption of critical contacts such
as salt bridges important for maintaining the bent mono-
mer. It is important to note that the model described in
Fig. 7 only deals with the first step of filament assembly. It
is possible that the interactions identified by the suppres-
sors could be between different molecules in higher or-
dered structures. These structures would be the subse-
quent steps of the filament assembly pathway. Thus, the
proline mutations may locally disrupt the thick filament
substructure such that the aspartate residues could be bet-
ter accommodated. This could shift the equilibrium to fa-
vor filament formation. Similarly, the shift of alignment by
the deletion mutations could disrupt critical contacts im-
portant for the thick filament structure.
It is interesting that no suppressors were found in region
A. One possibility is that any mutation in this region af-
fects another step in the pathway for thick filament assem-
bly, which is therefore unable to survive our screening pro-
cess. In fact, the second half of region A has been strongly
implicated in formation of parallel dimers (Pasternak et al.,
1989), which are the building blocks for thick filaments.
Several myosin II tail mutants have been constructed
with COOH-terminal and internal deletions. COOH-ter-
minal deletion mutants are functional to different extents
as long as the assembly domain (Fig. 7, blue) is intact, al-
lowing filaments to form (Egelhoff et al., 1991b; Lee et al.,
1994). Mutants that remove parts of the proposed tet-
rameric coiled–coil structure (region B; Fig. 7, green and
orange stripes) give rise to intermediate in vivo pheno-
types, indicating that regulation is impaired (Lee et al.,
1994). Deletions that remove fragments between the head
and region A (Fig. 7, gray stripes) appear to be functional,
but if part of region A is removed an intermediate pheno-
type is observed (Kubalak et al., 1992; Shu et al., 1999).
These observations are consistent with the proposal that
the tetrameric coiled–coil structure is important for effi-
cient regulation.
Phosphorylation of myosin II heavy chain has been
found to occur in a variety of nonmuscle cells as well as in
the catch muscle of mollusks, and may be a general mecha-
nism of regulating myosin II function (Tan et al., 1992). It
is possible that the hinges in the tail domains of these
other myosins are designed for regulation of myosin IIs
through a mechanism similar to that proposed here. The
Figure 7. A model for the bent conformation responsible for the regulation of the initial step of filament assembly. We propose that
regulation of the initial step of filament assembly results from the state of phosphorylation in the myosin II molecules. An unphosphor-
ylated myosin II molecule in the straight conformation is shown below. The two regions (A and B) rich in alanines are shown in dashed
patterns. Mutations mapped from the suppressors against 33Asp myosins are shown in orange (for single point mutations) and green
(for deletion mutations), and locate in region B. A bent phosphorylated myosin II molecule that folds at z1,200 Å from the head–neck
junction is shown, where the alanine-rich regions A and B overlap. Threonine pair 1823/1833 may be a nucleation site where the bent
monomer conformation is initiated after phosphorylation, followed by the formation of an antiparallel tetrameric coiled–coil in the ala-
nine-rich regions. The assembly domain (O’Halloran et al., 1990; Shoffner and De Lozanne, 1996; shown in blue) is sequestered as a
looped structure that is unable to self-assemble into higher-order structures.The Journal of Cell Biology, Volume 147, 1999 1046
bending position of Acanthamoeba myosin II locates at a
proportionally similar position as the Dictyostelium region
(Hammer et al., 1987). Furthermore, the Acanthamoeba
myosin II is phosphorylated at three serines located at the
end of the tail (Collins et al., 1982). However, it is contro-
versial whether phosphorylation regulates assembly of the
Acanthamoeba myosin II (Collins et al., 1982; Sinard and
Pollard, 1989).
Myosin II from a molluscan catch muscle is phosphory-
lated at two serines in the tail domain (Castellani et al.,
1988). After phosphorylation, myosin II solubility is en-
hanced and the molecule folds (Castellani and Cohen,
1987), reminiscent of the behavior of Dictyostelium myo-
sin II. Recently, heavy chain phosphorylation of verte-
brate nonmuscle myosin IIs and even of smooth muscle
myosin II has been reported (Korn and Hammer, 1988;
Kelley and Adelstein, 1990; Fukui and Morita, 1996). It re-
mains to be determined whether the model proposed in
this study is universal to myosin IIs that are regulated by
heavy chain phosphorylation.
Smooth muscle myosin II has two hinge regions located
at approximately one-third and two-thirds the length of
the tail from the head–neck junction domain (Tan et al.,
1992). Although little is known regarding the effects of
heavy chain phosphorylation for smooth muscle myosin, in
vitro regulation of conformational changes in this myosin,
and control of assembly has been reported to be mainly by
light chain phosphorylation (Craig et al., 1983; Trybus,
1989). However, there is controversy about the state or the
extent of light chain phosphorylation change in the fila-
mentous state of smooth muscle myosin II in vivo (Post
et al., 1995; Somlyo et al., 1981).
Cells have evolved intricate mechanisms for the control
of macromolecular assemblies. The myosin II thick fila-
ment is just one example where a delicately balanced
equilibrium between monomer and filament forms is
used to control cellular function. The model suggested
here proposes that phosphorylation on a single threonine
residue on a .200-kD protein results in stabilization of a
bent monomer form of the molecule. This structural
modification shifts the equilibrium to make filament as-
sembly less favorable. Specific kinases and phosphatases
can be activated, repressed, or spatially distributed to
provide the appropriate regulation signals. A related
model has been proposed for the regulation of the activ-
ity of heat shock factor in Drosophilia (Rabindran et al.,
1993). There, coiled–coil regions of the protein interact
within the protein as a monomer or between proteins as
the active trimer form. The regulation of macromolecular
assemblies via coiled–coil interactions is likely a widely
applicable, highly dynamic, important cellular mecha-
nism.
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